Key metrics to expanding the pipeline of successful antibody–drug conjugates
Author:
Funder
National Institutes of Health
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference59 articles.
1. Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody–drug conjugate (ADC);Goldenberg;Oncotarget,2015
2. A HER2-targeting antibody–drug conjugate, trastuzumab deruxtecan (DS-8201a), enhances antitumor immunity in a mouse model;Iwata;Mol. Cancer Ther.,2018
3. Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy;Cruz;Biologics,2019
4. Quantitative pharmacology in antibody–drug conjugate development: armed antibodies or targeted small molecules?;Nessler;Oncoscience,2018
5. Antibody–drug conjugates bearing pyrrolobenzodiazepine or tubulysin payloads are immunomodulatory and synergize with multiple immunotherapies;Rios-Doria;Cancer Res.,2017
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development of an ELISA with acidification treatment for an antibody conjugate incorporating Exatecans;Analytical Biochemistry;2024-07
2. In vivoAuto-tuning of Antibody-Drug Conjugate Delivery for Effective Immunotherapy using High-Avidity, Low-Affinity Antibodies;2024-04-10
3. Targeting CD33+ Acute Myeloid Leukemia with GLK-33, a Lintuzumab–Auristatin Conjugate with a Wide Therapeutic Window;Molecular Cancer Therapeutics;2024-04-01
4. Improving Intracellular Delivery of an Antibody–Drug Conjugate Targeting Carcinoembryonic Antigen Increases Efficacy at Clinically Relevant Doses In Vivo;Molecular Cancer Therapeutics;2023-12-11
5. Management of patients with HER2-positive metastatic breast cancer after trastuzumab deruxtecan failure;ESMO Open;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3